MMP9 and amyotrophic lateral sclerosis: These efforts have led Kaplan et al. (2014) to elegantly show that the matrix metalloproteinase-9 (mmp-9) is strongly expressed in spinal MNs, while absent from oculomotor and Onuf’s nuclei, becoming a therapeutic candidate for ALS treatment.